Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial ...

Maze Therapeutics is eyeing a $113 million initial public offering a little under two months after revealing a $115 million ...

Lines of tractors have taken to roads across Northern Ireland to protest against proposed changes to inheritance tax rules.

An international team of scientists have discovered that soap could be important to helping our understanding of complex ...

Farer has brought back its popular Maze GMT after a two-year hiatus, and the brand fixed the watch's biggest issue.

BYD shared a video showing the YangWang U7 leveraging the Disus-Z suspension system to complete a maze game via phone control ...

(Reuters) -Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial public offering in the United States. The South San Francisco, ...